Spectrum Pharma (NASDAQ: SPPI) reported Q2 EPS of ($0.23), $0.09 better than the analyst estimate of ($0.32).“We’ve made significant progress ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE